For U.S. Cardiologists. Age and Income Continue to Rise
For U.S. Cardiologists, Age and Income Continue to Rise

Despite expectations to the contrary, a new survey from cardiovascular healthcare consulting firm MedAxiom finds that overall, cardiology compensation continues to increase. The company’s fifth annual Cardiovascular Provider Compensation and Production Survey also revealed that one in five cardiologists is over the age of 61, and that overall compensation for private cardiologists is increasing faster than that of their integrated counterparts; the differential in compensation is at its lowest point in five years.

October 3, 2017 – Medical Metrics, an experienced core laboratory for multi-center clinical trials, has implemented the Digisonics Cardiovascular Information System (CVIS) for cardiology research. Digisonics provides cardiologists with remote functionality via Virtual Desktop Infrastructure (VDI), Digisonics’ latest platform validated for secured access to cardiology images.

October 2, 2017 — Cardiovascular healthcare membership organization and performance community MedAxiom announced its corporate partnership with pMD to help advance value-based cardiovascular healthcare. pMD is a healthcare technology provider that improves the physician experience and patient care through a platform focused on mobile charge capture and HIPAA-compliant information sharing.

October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Wingman14C Crossing Catheter for use in conjunction with a guidewire to access discrete regions of the coronary vasculature.

Medtronic plc recently announced a new post-market clinical study to evaluate its CoreValve Evolut Pro valve in everyday clinical practice. Studying patients with severe symptomatic aortic stenosis at an intermediate, high or extreme risk for open-heart surgery, the FORWARD PRO Clinical Study will evaluate longer-term performance (out to five years) of the next-generation self-expanding transcatheter aortic valve implantation (TAVI) system, which was recently approved for commercial use in Europe and United States.

October 2, 2017 — Boston Scientific announced a definitive agreement to acquire Apama Medical Inc., a privately-held company that is developing the Apama Radiofrequency (RF) Balloon Catheter System for the treatment of atrial fibrillation (AF). The deal calls for $175 million in cash up-front and a maximum of $125 million in contingent payments over the period of 2018-2020, based on achievements of clinical and regulatory milestones.

Abbott has pulled the Absorb Bioresorbable scaffold stent off the market.

October 2, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of September, based on website analytics of the month’s 126,393 pageviews:

Top Cardiology Technology Articles

1. Abbott Will End Sales of Absorb Bioresorbable Stent

September 29, 2017 — TherOx Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the premarket approval (PMA) application for its Supersaturated Oxygen (SSO2) Therapy system. The second-generation SSO2 Therapy system is designed to reduce infarct size and thereby improve outcomes in anterior acute myocardial infarction (AMI) patients treated within six hours of symptom onset.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now